BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 27402532)

  • 1. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.
    Kamiya N; Ye L; Kobayashi T; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
    Development; 2008 Nov; 135(22):3801-11. PubMed ID: 18927151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype.
    Kamiya N; Yamaguchi R; Aruwajoye O; Kim AJ; Kuroyanagi G; Phipps M; Adapala NS; Feng JQ; Kim HK
    J Bone Miner Res; 2017 Aug; 32(8):1716-1726. PubMed ID: 28425622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
    Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
    PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.
    Kamiya N; Kobayashi T; Mochida Y; Yu PB; Yamauchi M; Kronenberg HM; Mishina Y
    J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of bone morphogenetic protein type IA receptor in osteoblasts impairs bone quality and bone strength in mice.
    Bao Q; Li A; Chen S; Feng J; Liu H; Qin H; Li J; Liu D; Shen Y; Zong Z
    Cell Tissue Res; 2018 Nov; 374(2):263-273. PubMed ID: 29987355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass.
    Kamiya N; Ye L; Kobayashi T; Lucas DJ; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
    J Bone Miner Res; 2008 Dec; 23(12):2007-17. PubMed ID: 18684091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis.
    Jiao Z; Chai H; Wang S; Sun C; Huang Q; Xu W
    J Mol Med (Berl); 2023 May; 101(5):607-620. PubMed ID: 37121919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance.
    Zhao G; Huang BL; Rigueur D; Wang W; Bhoot C; Charles KR; Baek J; Mohan S; Jiang J; Lyons KM
    J Bone Miner Res; 2018 Jun; 33(6):1076-1089. PubMed ID: 29351359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.
    Spatz JM; Wein MN; Gooi JH; Qu Y; Garr JL; Liu S; Barry KJ; Uda Y; Lai F; Dedic C; Balcells-Camps M; Kronenberg HM; Babij P; Pajevic PD
    J Biol Chem; 2015 Jul; 290(27):16744-58. PubMed ID: 25953900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of BMP signaling through BMPR1A in osteoblasts leads to greater collagen cross-link maturation and material-level mechanical properties in mouse femoral trabecular compartments.
    Zhang Y; McNerny EG; Terajima M; Raghavan M; Romanowicz G; Zhang Z; Zhang H; Kamiya N; Tantillo M; Zhu P; Scott GJ; Ray MK; Lynch M; Ma PX; Morris MD; Yamauchi M; Kohn DH; Mishina Y
    Bone; 2016 Jul; 88():74-84. PubMed ID: 27113526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mef2c deletion in osteocytes results in increased bone mass.
    Kramer I; Baertschi S; Halleux C; Keller H; Kneissel M
    J Bone Miner Res; 2012 Feb; 27(2):360-73. PubMed ID: 22161640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connexin 43 deficiency desensitizes bone to the effects of mechanical unloading through modulation of both arms of bone remodeling.
    Lloyd SA; Loiselle AE; Zhang Y; Donahue HJ
    Bone; 2013 Nov; 57(1):76-83. PubMed ID: 23891909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversy of physiological vs. pharmacological effects of BMP signaling: Constitutive activation of BMP type IA receptor-dependent signaling in osteoblast lineage enhances bone formation and resorption, not affecting net bone mass.
    Kamiya N; Atsawasuwan P; Joiner DM; Waldorff EI; Goldstein S; Yamauchi M; Mishina Y
    Bone; 2020 Sep; 138():115513. PubMed ID: 32603910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity.
    Lau KH; Baylink DJ; Zhou XD; Rodriguez D; Bonewald LF; Li Z; Ruffoni D; Müller R; Kesavan C; Sheng MH
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E271-81. PubMed ID: 23715728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
    Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
    J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis.
    Kramer I; Halleux C; Keller H; Pegurri M; Gooi JH; Weber PB; Feng JQ; Bonewald LF; Kneissel M
    Mol Cell Biol; 2010 Jun; 30(12):3071-85. PubMed ID: 20404086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.
    Lin C; Jiang X; Dai Z; Guo X; Weng T; Wang J; Li Y; Feng G; Gao X; He L
    J Bone Miner Res; 2009 Oct; 24(10):1651-61. PubMed ID: 19419300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Osteocyte-PDL Crosstalk in Tooth Movement via SOST/Sclerostin.
    Odagaki N; Ishihara Y; Wang Z; Ei Hsu Hlaing E; Nakamura M; Hoshijima M; Hayano S; Kawanabe N; Kamioka H
    J Dent Res; 2018 Nov; 97(12):1374-1382. PubMed ID: 29863952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement.
    Shu R; Bai D; Sheu T; He Y; Yang X; Xue C; He Y; Zhao M; Han X
    PLoS One; 2017; 12(1):e0167312. PubMed ID: 28081119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.